MedTrace Logo

Anticipated and Perceived Benefits Following Hepatitis C Treatment

NCT03000023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-10-24

No results posted yet for this study

Summary

The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceive before and after viral eradication.

Conditions

  • Hepatitis C
  • Hepatitis C, Chronic

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Donna Evon, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000023 on ClinicalTrials.gov